Faruqi & Faruqi, LLP is Investigating CACI International Inc. on Behalf of its Shareholders (CACI)
Faruqi & Faruqi, LLP, a national law firm concentrating on investor rights, consumer rights and enforcement of federal antitrust laws, is investigating potential wrongdoing at CACI International Inc. (“CACI” or the “Company”) (NYSE: CACI). The investigation focuses on whether certain officers and directors of CACI breached their fiduciary duties by causing or permitting the Company to submit false claims in order to receive federal funds pursuant to a General Services Administration contract.
In a May 4, 2012 regulatory filing, the Company disclosed for the first time that it had received a subpoena from the U.S. Defense Department and a notice of a False Claims Act investigation by the U.S. Justice Department. The Company disclosed that “On April 9, 2012, the Company received a letter from the Department of Justice (DoJ) informing the Company that the DoJ is investigating whether the Company violated the Civil False Claims Act by submitting false claims to receive federal funds pursuant to a GSA contract. Specifically, the DoJ is investigating whether the Company failed to comply with certain contract requirements and applicable regulations by improperly billing for certain contracting personal under the contract.” The Company also disclosed that it received a subpoena from the Defense Criminal Investigative Service seeking documents related to one of the Company’s contracts for the period of January 1, 2007 through March 26, 2012.
If you are a current CACI shareholder, and you would like to discuss your legal rights, contact us by calling Beth Keller toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to email@example.com.
Please tell us about yourself by completing the form below and we will provide you with additional
information on how to join the Action.
* The submission of this form does not create an attorney-client relationship.
Faruqi & Faruqi, LLP
685 Third Avenue 26th Floor
New York, NY 10017
Tel: (212) 983-9330
If you have information regarding this case that you would like to make available, please click here to contact us about our investigation.